A performance improvement resource

             Tuesday, October 07, 2008

Patient Feedback Feasibility Study

 Thanks to the support and sagely 

 collaboration of colleagues in the National 

 Drug Abuse Clinical Trials Network, the  

 feasibility test of Patient Feedback has come 

 to a successful close. Researchers, 

 treatment organizations, and clinical staff all 

 pitched in with great generosity and spirit to 

 test this quality improvement intervention for 

 substance abuse group therapy. We are 

 grateful to all who helped make this study a  

 great success. For a list of the collaborating 

 partners and colleagues, please click here.

Patient Feedback Randomized Controlled Trial Funded by NIDA!

 The National Institute on Drug Abuse has

 funded, beginning May of 2006, a randomized

 controlled trial of the effectiveness of Patient

 Feedback. Grants have been made to the

 University of Pennsylvania (Paul Crits-

 Christoph, Principal Investigator) and New

 York University School of Medicine (John

 Rotrosen, M.D., Principal Investigator) to

 perform this study. Currently we are in the

 process of confirming site interest and

 selecting the clinics that will be involved in the

 study. We plan to enroll 32 outpatient

 addiction treatment programs in the

 Philadelphia and New York areas. Every clinic 

 will be given access to the Patient Feedback

 system, either immediately (the Intervention

 condition) or after a 3 month delay (the Control

 condition). Once clinic staff have been

 consented and trained in the study protocol,

 counselors and clinic supervisors will be

 allowed to distribute Patient Feedback  surveys to their groups and view feedback

 reports on the web. In addition, counselors

 and supervisors will meet as a team once a

 month to discuss strategies for performance

 improvement.

 We cannot allow open access to the 

 Patient Feedback materials while this 

 study is ongoing. However we look

 forward to wide dissemination of the

 Patient Feedback system at some point

 in the future

 

     FAQ

     E-mail

     Mail

     Phone

  23